3320:HKEXChina Resources Pharmaceutical Group Ltd. Analysis
Data as of 2026-09-09 - not real-time
HK$4.46
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
China Resources Pharmaceutical Group Limited is priced at HKD 4.46 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has lost 9.0%. RSI sits at 36.0, which reads as approaching oversold, and MACD momentum is bearish. Recent trading has carved out support near HKD 4.38 and resistance around HKD 5.02.
On valuation the read is undervalued — earnings multiple of 5.9 versus a 29.9 sector average, below the peer group. Consensus targets land 46.0% above where the shares trade now. Revenue is growing at 2.0% on a 1.5% profit margin. The 5.34% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 15.7%, a beta of 0.29 and a maximum drawdown of 34.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against buy longer out, with 4/10 conviction on the long call.
On valuation the read is undervalued — earnings multiple of 5.9 versus a 29.9 sector average, below the peer group. Consensus targets land 46.0% above where the shares trade now. Revenue is growing at 2.0% on a 1.5% profit margin. The 5.34% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 15.7%, a beta of 0.29 and a maximum drawdown of 34.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against buy longer out, with 4/10 conviction on the long call.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 4.82
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 5.9 versus sector average of 29.9
- Trading below the 200-day average of 4.82
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 5.9 versus sector average of 29.9
- Analyst targets imply +46.0% versus the current price
- Dividend yield of 5.34%
Key Metrics & Analysis
Financial Health
Revenue Growth2.00%
Profit Margin1.53%
P/E Ratio5.9
ROE8.32%
ROA2.64%
Debt/Equity65.78
P/B Ratio0.5
Industry P/E29.9
Technical Analysis
TrendBearish
RSI36.0
SupportHK$4.38
ResistanceHK$5.02
MA 20HK$4.64
MA 50HK$4.69
MA 200HK$4.82
MACDBearish
VolumeIncreasing
Fear & Greed Index93.36
Valuation
Target PriceHK$6.51
Upside/Downside45.96%
GradeUndervalued
TypeValue
Dividend Yield5.34%
Risk Assessment
Beta0.29
Volatility15.72%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.